Recombinant Streptococcus pyogenes serotype M5 Elongation factor Tu (tuf)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder. We will ship the format we have in stock. If you have special format requirements, please note them when ordering, and we will fulfill your request.
Lead Time
Delivery time varies by purchasing method and location. Consult your local distributor for specific delivery times. All proteins are shipped with standard blue ice packs. For dry ice shipping, contact us in advance; extra fees apply.
Notes
Avoid repeated freezing and thawing. Store working aliquots at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening to collect contents at the bottom. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer components, storage temperature, and protein stability. Generally, the liquid form has a 6-month shelf life at -20°C/-80°C. The lyophilized form has a 12-month shelf life at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receiving. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type is determined during manufacturing. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
tuf; SpyM51355Elongation factor Tu; EF-Tu
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-398
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Streptococcus pyogenes serotype M5 (strain Manfredo)
Target Names
tuf
Target Protein Sequence
MAKEKYDRSK PHVNIGTIGH VDHGKTTLTA AITTVLARRL PSSVNQPKDY ASIDAAPEER ERGITINTAH VEYETATRHY AHIDAPGHAD YVKNMITGAA QMDGAILVVA STDGPMPQTR EHILLSRQVG VKHLIVFMNK VDLVDDEELL ELVEMEIRDL LSEYDFPGDD LPVIQGSALK ALEGDTKFED IIMELMDTVD SYIPEPERDT DKPLLLPVED VFSITGRGTV ASGRIDRGTV RVNDEIEIVG IKEETKKAVV TGVEMFRKQL DEGLAGDNVG ILLRGVQRDE IERGQVIAKP GSINPHTKFK GEVYILSKDE GGRHTPFFNN YRPQFYFRTT DVTGSIELPA GTEMVMPGDN VTINVELIHP IAVEQGTTFS IREGGRTVGS GIVSEIEA
Uniprot No.

Target Background

Function
This protein promotes GTP-dependent binding of aminoacyl-tRNA to the ribosomal A-site during protein biosynthesis.
Database Links
Protein Families
TRAFAC class translation factor GTPase superfamily, Classic translation factor GTPase family, EF-Tu/EF-1A subfamily
Subcellular Location
Cytoplasm.

Q&A

What is Elongation factor Tu (tuf) in Streptococcus pyogenes and why is it significant in research?

Elongation factor Tu (tuf) is a highly conserved protein involved in protein synthesis in S. pyogenes, playing a critical role in delivering aminoacyl-tRNAs to the ribosome during translation. Its significance in research stems from its stable expression levels across various growth conditions, making it an ideal housekeeping gene for normalizing expression data in RT-qPCR experiments, as demonstrated in studies of the sag operon in S. pyogenes M5 .

When investigating gene expression changes in different genetic backgrounds or experimental conditions, tuf serves as a reliable internal control to obtain accurate relative expression values. Gene expression analyses typically involve extracting RNA from bacteria grown to specific phases, performing DNase treatment using kits like TURBO DNA-free Kit, and synthesizing cDNA with systems such as Protoscript II First Strand cDNA Synthesis . The tuf gene has become a standard reference for normalizing quantitative expression data when studying virulence factors and regulatory pathways in S. pyogenes.

How does Streptococcus pyogenes serotype M5 differ from other serotypes in terms of virulence factors?

The M5 serotype of S. pyogenes possesses distinct virulence characteristics primarily associated with its M protein structure. As detailed in functional dissection studies, the M5 protein contains specific regions including a hypervariable region (HVR), fibrinogen-binding B-repeats, and C-repeats, each contributing differently to virulence . The M5 protein's B-repeat region binds fibrinogen with high affinity, which significantly contributes to its ability to resist phagocytosis.

Mixed infection experiments have demonstrated that mutants lacking either the HVR or B-repeat regions are strongly attenuated in virulence, while mutants lacking the C-repeats show only slight attenuation . This emphasizes that M5's virulence mechanism relies heavily on both its HVR and fibrinogen-binding regions. Interestingly, studies have shown that the HVR of M5 protein plays a major role in virulence despite not being required for phagocytosis resistance, suggesting additional functions for this region beyond current understanding .

What are the most efficient methods for generating recombinant constructs of S. pyogenes tuf gene?

The most efficient approaches for generating recombinant constructs of S. pyogenes tuf gene leverage modern molecular cloning techniques that enable rapid and precise genetic manipulation. Based on methodologies described for other GAS genes, an efficient strategy would involve:

  • PCR amplification of the tuf gene from S. pyogenes M5 genomic DNA using high-fidelity polymerase and primers designed with appropriate restriction enzyme sites or assembly overhangs.

  • Implementation of Golden Gate assembly, which has proven effective for GAS gene constructs, allowing one-step assembly of multiple DNA fragments with type IIS restriction enzymes like BsaI .

  • Cloning into an expression vector containing a strong promoter and suitable tags for purification.

  • Transformation into E. coli for construct verification and protein expression optimization.

This approach enables the generation of recombinant tuf constructs in approximately 3 days, significantly faster than traditional approaches requiring thermosensitive plasmids that can take up to 2 weeks . For expression of functional recombinant Elongation factor Tu, careful consideration should be given to maintaining proper protein folding and potential post-translational modifications necessary for activity.

How can non-polar mutations in S. pyogenes genes be efficiently generated and validated?

Generating non-polar mutations in S. pyogenes genes requires specialized approaches to prevent effects on downstream gene expression. Based on recently developed methodologies, an efficient system includes:

  • Design of suicide plasmids containing upstream and downstream flanking regions (approximately 1 kb each) of the target gene, with a selectable marker like aphA3 (kanamycin resistance) replacing the gene of interest .

  • Assembly of these fragments using Golden Gate cloning, which allows precise one-step assembly using type IIS restriction enzymes like BsaI .

  • Transformation of the construct into S. pyogenes and selection of transformants using appropriate antibiotics (kanamycin for gene replacement).

  • Discrimination between single (KanᴿSpecᴿ) and double (KanᴿSpecˢ) recombinants by testing for spectinomycin sensitivity, as the vector backbone contains the aad9 (spectinomycin resistance) gene .

  • Validation of non-polar effects by RT-qPCR analysis of downstream gene expression, as demonstrated in the validation of sagB knockout where researchers confirmed no change in sagC expression levels compared to wild-type .

This method allows generation of non-polar mutants in just 3 days, compared to previous approaches requiring up to 2 weeks, and has been successfully applied to various genes and GAS M-types with success rates between 11% and 93% as shown in the following table:

StrainsTarget geneNumber of reisolated transformantsNumber of single recombinantsNumber of double recombinants% of success
M5 (LO1)sptR56154173
M75 (Emmy)mrp56332341
M75 (clinical strain)emm49292041
M25 (NCTC8306)emm6457711
M5 (LO1)isp24563987
M1 (SF370)hasA3022893

How can RT-qPCR be optimized when using tuf as a reference gene for expression studies in S. pyogenes?

Optimizing RT-qPCR with tuf as a reference gene for S. pyogenes expression studies requires careful attention to several methodological considerations:

  • RNA Extraction Protocol: For S. pyogenes, rapid preservation of RNA integrity is crucial. Recommended methodology involves immediately resuspending bacterial cells in RNA protect buffer followed by FastPrep 5G beads disruption for effective lysis of the thick peptidoglycan layer of this Gram-positive bacterium .

  • DNase Treatment: Thorough removal of genomic DNA contamination is essential, as described in protocols using TURBO DNA-free Kit, to prevent amplification of genomic tuf sequences .

  • Primer Design for tuf:

    • Design primers that span exon-exon junctions if possible

    • Ensure primers have similar annealing temperatures to target gene primers

    • Validate primer specificity through melt curve analysis

    • Optimize primer concentrations (typically 100-500 nM)

  • Validation of tuf Expression Stability:

    • Verify that tuf expression remains constant under your specific experimental conditions

    • Consider using multiple reference genes alongside tuf for more robust normalization

  • Data Analysis:

    • Apply appropriate normalization formulas (e.g., 2^-ΔΔCt method)

    • Include technical replicates (at least triplicates) and biological replicates

    • Apply statistical analysis to determine significance of expression changes

Following these optimization steps will ensure reliable results when using tuf as a reference gene for expression studies, as demonstrated in the analysis of sag operon expression where tuf normalization enabled accurate quantification of gene expression changes in mutant versus wild-type strains .

What approaches are most effective for studying M protein contributions to S. pyogenes virulence?

The most effective approaches for studying M protein contributions to S. pyogenes virulence combine genetic manipulation, biochemical characterization, and in vivo infection models:

  • Generation of Domain-Specific Deletion Mutants:

    • Create in-frame chromosomal deletions targeting specific regions (HVR, B-repeats, C-repeats)

    • Ensure mutant proteins are expressed in normal amounts on the bacterial surface

    • Verify that deletions only affect binding to the corresponding region but not adjacent regions

  • Functional Binding Assays:

    • Test binding of radiolabeled host proteins (like fibrinogen) to immobilized M proteins

    • Analyze binding of host proteins to whole bacteria expressing wild-type or mutant M proteins

    • Compare binding of proteins from different host species (e.g., mouse versus human fibrinogen)

  • Mixed Infection Experiments:

    • Prepare a mixture of wild-type and mutant strains in approximately 1:1 ratio

    • Infect animal models and harvest organs after appropriate time periods (~44 hours)

    • Calculate competitive index (CI) by comparing the ratio of strains in the inoculum versus recovered bacteria

  • Phagocytosis Resistance Testing:

    • Evaluate the ability of mutant strains to resist phagocytosis ex vivo

    • Correlate these findings with in vivo virulence data to identify discrepancies that may indicate additional functions

  • Cross-Functional Analysis:

    • Test mutants in hosts lacking specific factors (e.g., fibrinogen-deficient mice) to determine if protein domains have multiple functions

This comprehensive approach revealed unexpected findings about M5 protein, including the critical role of the HVR in virulence despite not affecting phagocytosis resistance, and the possibility that B-repeats have functions beyond fibrinogen binding .

How does Elongation factor Tu interact with host immune components during S. pyogenes M5 infection?

Elongation factor Tu (tuf) from S. pyogenes M5 exhibits multifunctional properties beyond its canonical role in protein synthesis, particularly in host-pathogen interactions. Although traditionally considered a cytoplasmic protein, research has shown that EF-Tu can be surface-exposed or released during infection, where it interacts with various host immune components:

  • Complement System Interactions:

    • EF-Tu may bind complement regulators similar to other bacterial moonlighting proteins

    • This interaction potentially contributes to complement evasion mechanisms

  • Fibrinogen Binding Potential:

    • While the M5 protein is the primary fibrinogen-binding protein in S. pyogenes , EF-Tu may have auxiliary fibrinogen-binding capabilities

    • This could contribute to the formation of a protective fibrin-like shield around the bacterium

  • Pattern Recognition Receptor Activation:

    • As a highly conserved bacterial protein, EF-Tu contains pathogen-associated molecular patterns (PAMPs)

    • These PAMPs can be recognized by host pattern recognition receptors, triggering inflammatory responses

Understanding these interactions requires sophisticated experimental approaches including protein-protein interaction studies, immune cell stimulation assays, and in vivo models examining the contribution of EF-Tu to virulence alongside established virulence factors like the M5 protein .

How do recombinant Elongation factor Tu and M5 protein interact with host fibrinogen, and what are the implications for virulence?

The interaction between recombinant S. pyogenes proteins and host fibrinogen reveals distinct mechanistic aspects of pathogenesis:

  • Binding Specificities:

    • M5 protein binds fibrinogen primarily through its B-repeat region, which is essential for virulence

    • The binding efficiency of M5 to mouse and human fibrinogen is comparable, making mouse models appropriate for studying this interaction

    • Binding studies using radiolabeled proteins demonstrated that M5 can bind immobilized fibrinogen of various species with similar efficacy

  • Experimental Evidence:

    • Dot-blot assays with immobilized fibrinogens and radiolabeled M5 protein show equivalent binding to mouse and human fibrinogen

    • Binding assays with whole bacteria demonstrated that wild-type S. pyogenes M5 strains bound both mouse and human fibrinogen, while ΔB mutants lacking B-repeats did not bind either

    • When incubated with whole plasma, M5-expressing bacteria selectively captured fibrinogen from both mouse and human plasma samples, confirming specificity

  • Virulence Correlation:

    • Mixed infection experiments showed that M5 mutants lacking the B-repeat region (ΔB) were strongly attenuated, similar to complete M5 deletion mutants

    • Unexpectedly, B-repeat mutants remained attenuated even in fibrinogen-deficient mice, suggesting the B-repeats have additional functions beyond fibrinogen binding

  • Methodological Approaches:

    • Competitive binding assays with recombinant proteins can determine if Elongation factor Tu competes with M5 for fibrinogen binding

    • Surface plasmon resonance analysis can provide precise binding kinetics and affinities

    • Structural studies may reveal the molecular basis for these interactions

Understanding the distinct and potentially complementary interactions of these proteins with host fibrinogen provides crucial insights into S. pyogenes pathogenesis mechanisms and may guide the development of novel therapeutic approaches.

What novel gene manipulation approaches can be applied to study tuf gene function in different S. pyogenes M-types?

Advanced genetic manipulation approaches for studying tuf gene function across different S. pyogenes M-types include:

  • One-Step Non-Polar Mutation System:

    • Recently developed methods allow generation of non-polar mutations in GAS in just 3 days compared to traditional 2-week approaches

    • The system uses suicide plasmids with flanking regions of the target gene and the aphA3 gene (kanamycin resistance) as a selective marker

    • Golden Gate assembly enables precise one-step construction of these plasmids

    • This approach has been successfully applied across various GAS backgrounds (M-types) with success rates between 11-93%

  • Counter-Selection Strategies:

    • Implementation of mutated pheS gene as a counter-selective marker for double recombination events

    • This allows efficient isolation of double recombinants through negative selection on chlorophenylalanine-containing media

    • For essential genes like tuf, conditional approaches using this system could be developed

  • Cross-M-type Applicability:

    • The methodology has been validated across multiple GAS backgrounds including M1, M5, M25, M75, and M98 clinical isolates

    • Success rates vary by strain and target gene as demonstrated in Table 1, providing predictive data for planning experiments

  • Validation Methods:

    • PCR confirmation of recombination events using primers that anneal outside the flanking regions and within the selective marker

    • RT-qPCR analysis to confirm absence of polar effects on downstream genes

    • Functional assays to verify phenotypic changes associated with the mutation

These advanced approaches enable more efficient functional characterization of tuf across diverse S. pyogenes strains, potentially revealing strain-specific variations in elongation factor function and contribution to virulence.

What are the future research directions for recombinant S. pyogenes M5 Elongation factor Tu?

Future research on recombinant S. pyogenes M5 Elongation factor Tu should focus on several promising directions:

  • Comprehensive Functional Mapping:

    • Structural and functional characterization of specific EF-Tu domains

    • Investigation of potential moonlighting functions beyond translation

    • Comparative analysis of EF-Tu across different S. pyogenes M-types

  • Host-Pathogen Interaction Studies:

    • Detailed examination of potential interactions between EF-Tu and host immune components

    • Investigation of possible synergies between EF-Tu and M protein in virulence

    • Exploration of how EF-Tu contributes to immune evasion strategies

  • Methodological Innovations:

    • Application of the rapid non-polar mutation system to generate conditional tuf mutants

    • Development of high-throughput screening systems for EF-Tu interactions

    • Implementation of advanced imaging techniques to visualize EF-Tu localization during infection

  • Therapeutic Applications:

    • Evaluation of EF-Tu as a potential broad-spectrum vaccine component

    • Assessment of EF-Tu as a target for novel antimicrobial compounds

    • Investigation of how EF-Tu modifications affect antibiotic susceptibility

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.